APYX logo

Apyx Medical Corporation Stock Price

NasdaqGS:APYX Community·US$162.0m Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

APYX Share Price Performance

US$4.04
2.62 (184.51%)
US$4.50
Fair Value
US$4.04
2.62 (184.51%)
10.2% undervalued intrinsic discount
US$4.50
Fair Value
Price US$4.04
AnalystConsensusTarget US$4.50

APYX Community Narratives

AnalystConsensusTarget·
Fair Value US$4.5 10.2% undervalued intrinsic discount

Minimally Invasive Aesthetic Procedures Will Expand International Markets

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
US$4.5
10.2% undervalued intrinsic discount
Revenue growth
7.49% p.a.
Profit Margin
13.54%
Future PE
32.78x
Share price in 2028
US$5.37

Updated Narratives

APYX logo

Minimally Invasive Aesthetic Procedures Will Expand International Markets

Fair Value: US$4.5 10.2% undervalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Fair value with mediocre balance sheet.

3 Risks
2 Rewards

Apyx Medical Corporation Key Details

US$47.9m

Revenue

US$17.9m

Cost of Revenue

US$30.0m

Gross Profit

US$44.5m

Other Expenses

-US$14.5m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-0.35
62.65%
-30.35%
569.2%
View Full Analysis

About APYX

Founded
1982
Employees
220
CEO
Charles Goodwin
WebsiteView website
apyxmedical.com

Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company’s helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Recent APYX News & Updates

Apyx Medical Corporation's (NASDAQ:APYX) Shares Leap 38% Yet They're Still Not Telling The Full Story

Nov 18
Apyx Medical Corporation's (NASDAQ:APYX) Shares Leap 38% Yet They're Still Not Telling The Full Story

Recent updates

No updates